Micro Labs launches anti-diabetic drug combo, Dapagliflozin plus Metformin EP News Bureau Nov 24, 2020 The drug comes in two strengths ZUCAPRIDE–M 500 priced at Rs12.80 per tablet and ZUCAPRIDE–M 1000 at Rs 14.80
SGLT-2 inhibitors may primarily drive growth of branded heart failure treatment market: GlobalData EP News Bureau Sep 15, 2020 Approximately 55 per cent of type T2D patients suffer from cardiovascular disease (CVD), which often leads to further…
Diabetes drug, Dapagliflozin shows benefits in patients with CKD EP News Bureau Aug 31, 2020 The drug, on top of standard of care, reduced the composite measure of worsening of renal function or risk of cardiovascular (CV)…
Glenmark gets tentative USFDA approval for generic anti-diabetes tablets Press Trust of India Apr 29, 2020 The approval is for the strength of 10 mg/5 mg tablets
Glenmark, Torrent Pharma ink licensing pact to co-market diabetes drug in India EP News Bureau Jul 11, 2019 Glenmark will manufacture and supply Remogliflozin while Torrent will market the drug under its own trademark 'Zucator' in India…
Sun Pharma partners with AstraZeneca India over Type II diabetes medicine Usha Sharma Mar 23, 2016 Under the agreement, Sun Pharma will promote and distribute dapagliflozin under the brand name 'Oxra'